drug

MRM-3379

1 story · latest Jul 17, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Mirum Pharmaceuticals, Inc.

Timeline

Mirum registers Phase 1 ADME trial for MRM-3379 in healthy male volunteers

Jul 17Trial updateMirum Pharmaceuticals, Inc.MRM-3379

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.